Literature DB >> 6289617

Carcinoma of the nasopharynx: results of radiation therapy.

E Cellai, A Chiavacci, P Olmi, M L Carcangiu.   

Abstract

Of a series of 186 patients with nasopharyngeal neoplasm 138 cases were treated with curative irradiation between 1959 and 1978. All cases were reviewed and retrospectively classified according to the TNM system. The 5-year crude survival rate was 39.5 per cent. A better prognosis was found for women and for younger age groups. The degree of neck node involvement had more prognostic value than the extent of the primary tumor. The causes of failure were analyzed. In 35 cases distant metastases were observed.

Entities:  

Mesh:

Year:  1982        PMID: 6289617     DOI: 10.3109/02841868209133989

Source DB:  PubMed          Journal:  Acta Radiol Oncol        ISSN: 0349-652X


  5 in total

1.  Carcinoma of the nasopharynx--comparison of the UICC and Ho clinical staging systems.

Authors:  S L Roth; G Bertram; H Sack
Journal:  Klin Wochenschr       Date:  1989-01-20

2.  A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: Evolving technical choices and survival.

Authors:  S Tonoli; S M Magrini; L Costa; F Paiar; G Simontacchi; V Scotti; N Pasinetti; R Barca; D Barbieri; A De Stefani; E Cellai; M Buglione; G Biti
Journal:  Radiol Med       Date:  2011-11-17       Impact factor: 3.469

Review 3.  Contribution of radiotherapy to function preservation and cancer outcome in primary treatment of nasopharyngeal carcinoma.

Authors:  Anne W M Lee
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

4.  Computerized tomographic evaluation of tumors of the nasopharynx and maxillary sinus: potential impact on results of treatment.

Authors:  O K Abayomi; M S Bankoff
Journal:  J Natl Med Assoc       Date:  1986-04       Impact factor: 1.798

5.  Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients.

Authors:  Shuna Li; Lihua Hang; Yongming Ma; Chaoyang Wu
Journal:  J Cell Mol Med       Date:  2016-08-04       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.